Skip to main content
. 2023 Jan 9;46(7):1429–1439. doi: 10.1007/s40618-022-02002-2

Fig. 2.

Fig. 2

Subgroup analyses. The primary analysis was performed after stratification based on diabetes duration and eGFR quartiles. Results are shown as relative risk (RR) for dapagliflozin versus DPP-4i with 95 confidence interval (CI)